Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nicholas

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated diseaseAlessia Bianchi, Rosa Cortese, Ferran Prados, et al.
Annals of Neurology|April 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort StudyPaolo Antonio Muraro, Antonio Zito, Alessio Signori, et al.
Nutrients|November 13, 2025
Mediterranean and MIND Dietary Patterns and Cognitive Performance in Multiple Sclerosis: A Cross-Sectional Analysis of the UK Multiple Sclerosis RegisterMaggie Yu, Steve Simpson-Yap, Annalaura Lerede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 3, 2021
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS RegisterAfagh Garjani, Rachael Hunter, Graham R Law, et al.
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 28, 2017
Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple MyelomaMeera Mohan, Rohan S Samant, Donghoon Yoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2014
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PETAlessandro Colasanti, Qi Guo, Nils Muhlert, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
Journal of the Neurological Sciences|March 18, 2022
The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implicationsCarolyn A Young, Roger Mills, Dawn Langdon, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated diseaseAlessia Bianchi, Rosa Cortese, Ferran Prados, et al.
Annals of Neurology|April 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort StudyPaolo Antonio Muraro, Antonio Zito, Alessio Signori, et al.
Nutrients|November 13, 2025
Mediterranean and MIND Dietary Patterns and Cognitive Performance in Multiple Sclerosis: A Cross-Sectional Analysis of the UK Multiple Sclerosis RegisterMaggie Yu, Steve Simpson-Yap, Annalaura Lerede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 3, 2021
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS RegisterAfagh Garjani, Rachael Hunter, Graham R Law, et al.
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 28, 2017
Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple MyelomaMeera Mohan, Rohan S Samant, Donghoon Yoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2014
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PETAlessandro Colasanti, Qi Guo, Nils Muhlert, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
Journal of the Neurological Sciences|March 18, 2022
The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implicationsCarolyn A Young, Roger Mills, Dawn Langdon, et al.
Pageof 17